A critical discovery in cancer research is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This vital malignant protector protein is frequently inactivated in various forms of tumors, leading https://fatallisto.com/story12112973/mini-antibodies-revive-the-p53-protein-new-promising-pathway-for-tumor-management